Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2011 Sep;226(9):2215-21.
doi: 10.1002/jcp.22561.

The p53 tumor suppressor protein regulates hematopoietic stem cell fate

Affiliations
Review

The p53 tumor suppressor protein regulates hematopoietic stem cell fate

Takashi Asai et al. J Cell Physiol. 2011 Sep.

Abstract

The p53 tumor suppressor protein is a key transcription factor that regulates several signaling pathways involved in the cell's response to stress. Through stress-induced activation, p53 accumulates and triggers the expression of target genes that protect the genetic integrity of all cells including hematopoietic stem cells (HSCs). These protective mechanisms include cell-cycle arrest, DNA repair, induction of apoptosis, or initiation of senescence. In addition to its function under stress conditions, p53 has important functions during steady-state hematopoiesis, regulating HSC quiescence and self-renewal. In addition, it appears that p53 levels affect HSC competition for the hematopoietic niche, with the less p53 activated HSCs preferentially surviving. The specific genes and precise mechanisms underlying p53's effects on normal HSCs are slowly being clarified. p53 also plays an important role in leukemia stem cell (LSC) behavior, with p53 loss affecting drug resistance and disease progression. Pharmacologic activation of p53 function could overcome the adverse impact of p53 inactivation in LSCs. Thus, understanding the p53 regulatory mechanisms active in HSCs and LSCs may promote the development of new therapeutic strategies that could eliminate the population of largely quiescent LSCs.

PubMed Disclaimer

Figures

Fig 1
Fig 1. Multiple functions of p53 at physiological and stress conditions
p53 can induce a variety of cellular responses depending on the nature, level and duration of stress signals. When expressed at low level under physiological condition, p53 plays homeostatic roles such as anti-oxidant function and maintenance of stem cell functions. Increasing level of stress augments the level of p53 expression which induces apoptosis, thereby eliminate damaged cells.
Fig 2
Fig 2. Role of p53 in hematopoietic stem cells
(A) Under normal condition, p53 has been shown to regulate hematopoietic stem cell quiescence mediated by Gfi-1 and Necdin. It is likely to maintain self-renewal by yet unknown mechanism. (B) Increasing level of stress triggers ATM activation which will increase p53 activation. By downstream mediators such as p21, Puma and Slug, p53 triggers cell cycle arrest, DNA repair or apoptosis.

References

    1. Ahuja H, Bar-Eli M, Advani SH, Benchimol S, Cline MJ. Alterations in the p53 gene and the clonal evolution of the blast crisis of chronic myelocytic leukemia. Proc Natl Acad Sci U S A. 1989;86(17):6783–6787. - PMC - PubMed
    1. Akala OO, Park IK, Qian D, Pihalja M, Becker MW, Clarke MF. Long-term haematopoietic reconstitution by Trp53−/−p16Ink4a−/−p19Arf−/− multipotent progenitors. Nature. 2008;453(7192):228–232. - PubMed
    1. Arai F, Hirao A, Ohmura M, Sato H, Matsuoka S, Takubo K, Ito K, Koh GY, Suda T. Tie2/angiopoietin-1 signaling regulates hematopoietic stem cell quiescence in the bone marrow niche. Cell. 2004;118(2):149–161. - PubMed
    1. Attar EC, Scadden DT. Regulation of hematopoietic stem cell growth. Leukemia. 2004;18(11):1760–1768. - PubMed
    1. Baker SJ, Fearon ER, Nigro JM, Hamilton SR, Preisinger AC, Jessup JM, vanTuinen P, Ledbetter DH, Barker DF, Nakamura Y, White R, Vogelstein B. Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. Science. 1989;244(4901):217–221. - PubMed

Publication types

Substances